Skip to main content
Log in

Comparison of different sources of mesenchymal stem cells: focus on inflammatory bowel disease

  • Review
  • Published:
Inflammopharmacology Aims and scope Submit manuscript

Abstract

Inflammatory bowel disease (IBD) poses a significant challenge in modern medicine, with conventional treatments limited by efficacy and associated side effects, necessitating innovative therapeutic approaches. Mesenchymal stem cells (MSC) have emerged as promising candidates for IBD treatment due to their immunomodulatory properties and regenerative potential. This thesis aims to explore and compare various sources of MSC and evaluate their efficacy in treating IBD. This study comprehensively analyses MSC derived from multiple sources, including bone marrow, adipose tissue, umbilical cord, and other potential reservoirs. Core elements of this investigation include assessing differences in cell acquisition, immunomodulatory effects, and differentiation capabilities among these MSC sources, as well as comparing their clinical trial outcomes in IBD patients to their therapeutic efficacy in animal models. Through meticulous evaluation and comparative analysis, this thesis aims to elucidate disparities in the efficacy of different MSC sources for IBD treatment, thereby identifying the most promising therapeutic applications. The findings of this study are intended to advance our understanding of MSC biology and offer valuable insights for selecting the most effective MSC sources for personalized IBD therapy. Ultimately, this research endeavor will optimise therapeutic strategies for managing inflammatory bowel disease through the utilization of MSC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  • Abdel Salam AG, Ata HM, Salman TM, Rashed LA, Sabry D, Schaalan MF (2014) Potential therapeutic utility of mesenchymal stem cells in inflammatory bowel disease in mice. Int Immunopharmacol 22:515–521

    Article  CAS  PubMed  Google Scholar 

  • Abraham C, Cho JH (2009) Inflammatory bowel disease. N Engl J Med 361:2066–2078

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Agerberth B, Charo J, Werr J, Olsson B, Idali F, Lindbom L, Kiessling R, Jörnvall H, Wigzell H, Gudmundsson GH (2000) The human antimicrobial and chemotactic peptides LL-37 and alpha-defensins are expressed by specific lymphocyte and monocyte populations. Blood 96:3086–3093

    Article  CAS  PubMed  Google Scholar 

  • Aggarwal S, Pittenger MF (2005) Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105:1815–1822

    Article  CAS  PubMed  Google Scholar 

  • Alfaifi M, Eom YW, Newsome PN, Baik SK (2018) Mesenchymal stromal cell therapy for liver diseases. J Hepatol 68:1272–1285

    Article  CAS  PubMed  Google Scholar 

  • Amable PR, Teixeira MV, Carias RB, Granjeiro JM, Borojevic R (2014) Protein synthesis and secretion in human mesenchymal cells derived from bone marrow, adipose tissue and Wharton’s jelly. Stem Cell Res Ther 5:53

    Article  PubMed  PubMed Central  Google Scholar 

  • Andaloussi SEL, Mäger I, Breakefield XO, Wood MJ (2013) Extracellular vesicles: biology and emerging therapeutic opportunities. Nat Rev Drug Discov 12:347–357

    Article  PubMed  Google Scholar 

  • Andrzejewska A, Lukomska B, Janowski M (2019) Concise review: mesenchymal stem cells: from roots to boost. Stem Cells 37:855–864

    Article  PubMed  Google Scholar 

  • Ankrum J, Karp JM (2010) Mesenchymal stem cell therapy: two steps forward, one step back. Trends Mol Med 16:203–209

    Article  PubMed  PubMed Central  Google Scholar 

  • Attar-Schneider O, Zismanov V, Drucker L, Gottfried M (2016) Secretome of human bone marrow mesenchymal stem cells: an emerging player in lung cancer progression and mechanisms of translation initiation. Tumour Biol 37:4755–4765

    Article  CAS  PubMed  Google Scholar 

  • Bailey CC, Zhong G, Huang IC, Farzan M (2014) IFITM-family proteins: the cell’s first line of antiviral defense. Annu Rev Virol 1:261–283

    Article  PubMed  PubMed Central  Google Scholar 

  • Bárcia RN, Santos JM, Filipe M, Teixeira M, Martins JP, Almeida J, Água-Doce A, Almeida SC, Varela A, Pohl S, Dittmar KE, Calado S, Simões SI, Gaspar MM, Cruz ME, Lindenmaier W, Graça L, Cruz H, Cruz PE (2015) What makes umbilical cord tissue-derived mesenchymal stromal cells superior immunomodulators when compared to bone marrow derived mesenchymal stromal cells? Stem Cells Int 2015:583984

    Article  PubMed  PubMed Central  Google Scholar 

  • Barnhoorn MC, Wasser M, Roelofs H, Maljaars PWJ, Molendijk I, Bonsing BA, Oosten LEM, Dijkstra G, Van der Woude CJ, Roelen DL, Zwaginga JJ, Verspaget HW, Fibbe WE, Hommes DW, Peeters K, Van der Meulen-de Jong AE (2020) Long-term evaluation of allogeneic bone marrow-derived mesenchymal stromal cell therapy for Crohn’s disease perianal fistulas. J Crohns Colitis 14:64–70

    Article  PubMed  Google Scholar 

  • Bernstein CN (2015) Treatment of IBD: where we are and where we are going. Am J Gastroenterol 110:114–126

    Article  PubMed  Google Scholar 

  • Bluguermann C, Wu L, Petrigliano F, Mcallister D, Miriuka S, Evseenko DA (2013) Novel aspects of parenchymal-mesenchymal interactions: from cell types to molecules and beyond. Cell Biochem Funct 31:271–280

    Article  CAS  PubMed  Google Scholar 

  • Brogden KA (2005) Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat Rev Microbiol 3:238–250

    Article  CAS  PubMed  Google Scholar 

  • Cao L, Xu H, Wang G, Liu M, Tian D, Yuan Z (2019) Extracellular vesicles derived from bone marrow mesenchymal stem cells attenuate dextran sodium sulfate-induced ulcerative colitis by promoting M2 macrophage polarization. Int Immunopharmacol 72:264–274

    Article  CAS  PubMed  Google Scholar 

  • Chang CP, Chio CC, Cheong CU, Chao CM, Cheng BC, Lin MT (2013) Hypoxic preconditioning enhances the therapeutic potential of the secretome from cultured human mesenchymal stem cells in experimental traumatic brain injury. Clin Sci (lond) 124:165–176

    Article  CAS  PubMed  Google Scholar 

  • Chen Z, He X, He X, Chen X, Lin X, Zou Y, Wu X, Lan P (2014) Bone marrow mesenchymal stem cells ameliorate colitis-associated tumorigenesis in mice. Biochem Biophys Res Commun 450:1402–1408

    Article  CAS  PubMed  Google Scholar 

  • Cheng MT, Yang HW, Chen TH, Lee OK (2009) Isolation and characterization of multipotent stem cells from human cruciate ligaments. Cell Prolif 42:448–460

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Choi A, Park SE, Jeong JB, Choi SJ, Oh SY, Ryu GH, Lee J, Jeon HB, Chang JW (2020) Anti-fibrotic effect of human Wharton’s Jelly-derived mesenchymal stem cells on skeletal muscle cells, mediated by secretion of MMP-1. Int J Mol Sci 21

  • Chong PP, Selvaratnam L, Abbas AA, Kamarul T (2012) Human peripheral blood derived mesenchymal stem cells demonstrate similar characteristics and chondrogenic differentiation potential to bone marrow derived mesenchymal stem cells. J Orthop Res 30:634–642

    Article  CAS  PubMed  Google Scholar 

  • Ciccocioppo R, Bernardo ME, Sgarella A, Maccario R, Avanzini MA, Ubezio C, Minelli A, Alvisi C, Vanoli A, Calliada F, Dionigi P, Perotti C, Locatelli F, Corazza GR (2011) Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn’s disease. Gut 60:788–798

    Article  PubMed  Google Scholar 

  • Ciccocioppo R, Gallia A, Sgarella A, Kruzliak P, Gobbi PG, Corazza GR (2015) Long-term follow-up of crohn disease fistulas after local injections of bone marrow-derived mesenchymal stem cells. Mayo Clin Proc 90:747–755

    Article  PubMed  Google Scholar 

  • Cosnes J, Gower-Rousseau C, Seksik P, Cortot A (2011) Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology 140:1785–1794

    Article  PubMed  Google Scholar 

  • Coward S, Clement F, Benchimol EI, Bernstein CN, Avina-Zubieta JA, Bitton A, Carroll MW, Hazlewood G, Jacobson K, Jelinski S, Deardon R, Jones JL, Kuenzig ME, Leddin D, Mcbrien KA, Murthy SK, Nguyen GC, Otley AR, Panaccione R, Rezaie A, Rosenfeld G, PeñA-Sánchez JN, Singh H, Targownik LE, Kaplan GG (2019) Past and future burden of inflammatory bowel diseases based on modeling of population-based data. Gastroenterology 156:1345-1353.e4

    Article  PubMed  Google Scholar 

  • De Robertis M, Massi E, Poeta ML, Carotti S, Morini S, Cecchetelli L, Signori E, Fazio VM (2011) The AOM/DSS murine model for the study of colon carcinogenesis: from pathways to diagnosis and therapy studies. J Carcinog 10:9

    Article  PubMed  PubMed Central  Google Scholar 

  • Dige A, Hougaard HT, Agnholt J, Pedersen BG, Tencerova M, Kassem M, Krogh K, Lundby L (2019) Efficacy of injection of freshly collected autologous adipose tissue into perianal fistulas in patients with Crohn’s disease. Gastroenterology 156:2208-2216.e1

    Article  PubMed  Google Scholar 

  • Ding M, Shen Y, Wang P, Xie Z, Xu S, Zhu Z, Wang Y, Lyu Y, Wang D, Xu L, Bi J, Yang H (2018) Exosomes isolated from human umbilical cord mesenchymal stem cells alleviate neuroinflammation and reduce amyloid-beta deposition by modulating microglial activation in Alzheimer’s disease. Neurochem Res 43:2165–2177

    Article  CAS  PubMed  Google Scholar 

  • Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D, Horwitz E (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8:315–317

    Article  CAS  PubMed  Google Scholar 

  • Duijvestein M, Vos AC, Roelofs H, Wildenberg ME, Wendrich BB, Verspaget HW, Kooy-Winkelaar EM, Koning F, Zwaginga JJ, Fidder HH, Verhaar AP, Fibbe WE, Van den Brink GR, Hommes DW (2010) Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn’s disease: results of a phase I study. Gut 59:1662–1669

    Article  PubMed  Google Scholar 

  • Duran NE, Hommes DW (2016) Stem cell-based therapies in inflammatory bowel disease: promises and pitfalls. Therap Adv Gastroenterol 9:533–547

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Eiró N, Sendon-Lago J, Seoane S, Bermúdez MA, Lamelas ML, Garcia-Caballero T, Schneider J, Perez-Fernandez R, Vizoso FJ (2014) Potential therapeutic effect of the secretome from human uterine cervical stem cells against both cancer and stromal cells compared with adipose tissue stem cells. Oncotarget 5:10692–10708

    Article  PubMed  PubMed Central  Google Scholar 

  • Eiro N, Fraile M, González-Jubete A, González LO, Vizoso FJ (2022) Mesenchymal (stem) stromal cells based as new therapeutic alternative in inflammatory bowel disease: basic mechanisms, experimental and clinical evidence, and challenges. Int J Mol Sci 23

  • Fan J, Varshney RR, Ren L, Cai D, Wang DA (2009) Synovium-derived mesenchymal stem cells: a new cell source for musculoskeletal regeneration. Tissue Eng Part B Rev 15:75–86

    Article  CAS  PubMed  Google Scholar 

  • Fernández-Francos S, Eiro, N, Costa LA, Escudero-Cernuda S, Fernández-Sánchez ML, Vizoso FJ (2021) Mesenchymal stem cells as a cornerstone in a galaxy of intercellular signals: basis for a new era of medicine. Int J Mol Sci 22

  • Fournier BP, Ferre FC, Couty L, Lataillade JJ, Gourven M, Naveau A, Coulomb B, Lafont A, Gogly B (2010) Multipotent progenitor cells in gingival connective tissue. Tissue Eng Part A 16:2891–2899

    Article  PubMed  Google Scholar 

  • Francis MP, Sachs PC, Elmore LW, Holt SE (2010) Isolating adipose-derived mesenchymal stem cells from lipoaspirate blood and saline fraction. Organogenesis 6:11–14

    Article  PubMed  PubMed Central  Google Scholar 

  • García-Olmo D, García-Arranz M, García LG, Cuellar ES, Blanco IF, Prianes LA, Montes JA, Pinto FL, Marcos DH, García-Sancho L (2003) Autologous stem cell transplantation for treatment of rectovaginal fistula in perianal Crohn’s disease: a new cell-based therapy. Int J Colorectal Dis 18:451–454

    Article  PubMed  Google Scholar 

  • García-Olmo D, García-Arranz M, Herreros D, Pascual I, Peiro C, Rodríguez-Montes JA (2005) A phase I clinical trial of the treatment of Crohn’s fistula by adipose mesenchymal stem cell transplantation. Dis Colon Rectum 48:1416–1423

    Article  PubMed  Google Scholar 

  • Garcia-Olmo D, Herreros D, Pascual I, Pascual JA, Del-Valle E, Zorrilla J, De-la-Quintana P, Garcia-Arranz M, Pascual M (2009) Expanded adipose-derived stem cells for the treatment of complex perianal fistula: a phase II clinical trial. Dis Colon Rectum 52:79–86

    Article  PubMed  Google Scholar 

  • Gauthaman K, Fong CY, Arularasu S, Subramanian A, Biswas A, Choolani M, Bongso A (2013) Human Wharton’s jelly stem cell conditioned medium and cell-free lysate inhibit human osteosarcoma and mammary carcinoma cell growth in vitro and in xenograft mice. J Cell Biochem 114:366–377

    Article  CAS  PubMed  Google Scholar 

  • Gholizadeh-Ghaleh Aziz S, Fardyazar Z, Pashaiasl M (2019) The human amniotic fluid mesenchymal stem cells therapy on, SKOV3, ovarian cancer cell line. Mol Genet Genomic Med 7:e00726

    Article  PubMed  PubMed Central  Google Scholar 

  • Gonzalez ME, Martin EE, Anwar T, Arellano-Garcia C, Medhora N, Lama A, Chen YC, Tanager KS, Yoon E, Kidwell KM, Ge C, Franceschi RT, Kleer CG (2017) Mesenchymal stem cell-induced DDR2 mediates stromal-breast cancer interactions and metastasis growth. Cell Rep 18:1215–1228

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Greco KA, Franzen CA, Foreman KE, Flanigan RC, Kuo PC, Gupta GN (2016) PLK-1 Silencing in bladder cancer by siRNA delivered with exosomes. Urology 91:241.e1–7

    Article  PubMed  Google Scholar 

  • Guadalajara H, Herreros D, De-la-Quintana P, Trebol J, Garcia-Arranz M, Garcia-Olmo D (2012) Long-term follow-up of patients undergoing adipose-derived adult stem cell administration to treat complex perianal fistulas. Int J Colorectal Dis 27:595–600

    Article  PubMed  Google Scholar 

  • Halvorsen YC, Wilkison WO, Gimble JM (2000) Adipose-derived stromal cells–their utility and potential in bone formation. Int J Obes Relat Metab Disord 24(Suppl 4):S41–S44

    Article  CAS  PubMed  Google Scholar 

  • Han I, Kwon BS, Park HK, Kim KS (2017) Differentiation potential of mesenchymal stem cells is related to their intrinsic mechanical properties. Int Neurourol J 21:S24-31

    Article  PubMed  PubMed Central  Google Scholar 

  • Hass R, Kasper C, Böhm S, Jacobs R (2011) Different populations and sources of human mesenchymal stem cells (MSC): a comparison of adult and neonatal tissue-derived MSC. Cell Commun Signal 9:12

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Haynesworth SE, Goshima J, Goldberg VM, Caplan AI (1992) Characterization of cells with osteogenic potential from human marrow. Bone 13:81–88

    Article  CAS  PubMed  Google Scholar 

  • He S, Gleason J, Fik-Rymarkiewicz E, Difiglia A, Bharathan M, Morschauser A, Djuretic I, Xu Y, Krakovsky M, Jankovic V, Buensuceso C, Edinger J, Herzberg U, Hofgartner W, Hariri R (2017) Human placenta-derived mesenchymal stromal-like cells enhance angiogenesis via T cell-dependent reprogramming of macrophage differentiation. Stem Cells 35:1603–1613

    Article  CAS  PubMed  Google Scholar 

  • He R, Han C, Li Y, Qian W, Hou X (2021) Cancer-preventive role of bone marrow-derived mesenchymal stem cells on colitis-associated colorectal cancer: roles of gut microbiota involved. Front Cell Dev Biol 9:642948

    Article  PubMed  PubMed Central  Google Scholar 

  • Heidari N, Abbasi-Kenarsari H, Namaki S, Baghaei K, Zali MR, Ghaffari Khaligh S, Hashemi SM (2021) Adipose-derived mesenchymal stem cell-secreted exosome alleviates dextran sulfate sodium-induced acute colitis by Treg cell induction and inflammatory cytokine reduction. J Cell Physiol 236:5906–5920

    Article  CAS  PubMed  Google Scholar 

  • Hoang VT, Trinh QM, Phuong DTM, Bui HTH, Hang LM, Ngan NTH, Anh NTT, Nhi PY, Nhung TTH, Lien HT, Nguyen TD, Thanh LN, Hoang DM (2021) Standardized xeno- and serum-free culture platform enables large-scale expansion of high-quality mesenchymal stem/stromal cells from perinatal and adult tissue sources. Cytotherapy 23:88–99

    Article  CAS  PubMed  Google Scholar 

  • Hsieh JY, Fu YS, Chang SJ, Tsuang YH, Wang HW (2010) Functional module analysis reveals differential osteogenic and stemness potentials in human mesenchymal stem cells from bone marrow and Wharton’s jelly of umbilical cord. Stem Cells Dev 19:1895–1910

    Article  CAS  PubMed  Google Scholar 

  • Hu HH, Chen DQ, Wang YN, Feng YL, Cao G, Vaziri ND, Zhao YY (2018) New insights into TGF-β/Smad signaling in tissue fibrosis. Chem Biol Interact 292:76–83

    Article  CAS  PubMed  Google Scholar 

  • Hu J, Chen Y, Huang Y, Su Y (2020) Human umbilical cord mesenchymal stem cell-derived exosomes suppress dermal fibroblasts-myofibroblats transition via inhibiting the TGF-β1/Smad 2/3 signaling pathway. Exp Mol Pathol 115:104468

    Article  CAS  PubMed  Google Scholar 

  • Hue S, Ahern P, Buonocore S, Kullberg MC, Cua DJ, Mckenzie BS, Powrie F, Maloy KJ (2006) Interleukin-23 drives innate and T cell-mediated intestinal inflammation. J Exp Med 203:2473–2483

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • In‘t Anker PS, Scherjon SA, Kleijburg-van der Keur C, De Groot-Swings GM, Claas FH, Fibbe WE, Kanhai HH (2004) Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. Stem Cells 22:1338–1345

    Article  PubMed  Google Scholar 

  • Ivanova-Todorova E, Bochev I, Mourdjeva M, Dimitrov R, Bukarev D, Kyurkchiev S, Tivchev P, Altunkova I, Kyurkchiev DS (2009) Adipose tissue-derived mesenchymal stem cells are more potent suppressors of dendritic cells differentiation compared to bone marrow-derived mesenchymal stem cells. Immunol Lett 126:37–42

    Article  CAS  PubMed  Google Scholar 

  • Jneid H, Anderson JL, Wright RS, Adams CD, Bridges CR, Casey DE Jr, Ettinger SM, Fesmire FM, Ganiats TG, Lincoff AM, Peterson ED, Philippides GJ, Theroux P, Wenger NK, Zidar JP (2012) 2012 ACCF/AHA focused update of the guideline for the management of patients with unstable angina/non-ST-elevation myocardial infarction (updating the 2007 guideline and replacing the 2011 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 60:645–681

    Article  PubMed  Google Scholar 

  • Jung KJ, Lee GW, Park CH, Lee TJ, Kim JY, Sung EG, Kim SY, Jang BI, Song IH (2020) Mesenchymal stem cells decrease oxidative stress in the bowels of interleukin-10 knockout mice. Gut Liver 14:100–107

    Article  CAS  PubMed  Google Scholar 

  • Kalamegam G, Sait KHW, Ahmed F, Kadam R, Pushparaj PN, Anfinan N, Rasool M, Jamal MS, Abu-Elmagd M, Al-Qahtani M (2018) Human Wharton’s Jelly Stem Cell (hWJSC) extracts inhibit ovarian cancer cell lines OVCAR3 and SKOV3 in vitro by inducing cell cycle arrest and apoptosis. Front Oncol 8:592

    Article  PubMed  PubMed Central  Google Scholar 

  • Kern S, Eichler H, Stoeve J, Klüter H, Bieback K (2006) Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 24:1294–1301

    Article  CAS  PubMed  Google Scholar 

  • Kidd S, Spaeth E, Watson K, Burks J, Lu H, Klopp A, Andreeff M, Marini FC (2012) Origins of the tumor microenvironment: quantitative assessment of adipose-derived and bone marrow-derived stroma. PLoS ONE 7:e30563

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kim HS, Shin TH, Lee BC, Yu KR, Seo Y, Lee S, Seo MS, Hong IS, Choi SW, Seo KW, Núñez G, Park JH, Kang KS (2013) Human umbilical cord blood mesenchymal stem cells reduce colitis in mice by activating NOD2 signaling to COX2. Gastroenterology 145:1392–403.e1–8

  • Koh GY, Kane A, Lee K, Xu Q, Wu X, Roper J, Mason JB, Crott JW (2018) Parabacteroides distasonis attenuates toll-like receptor 4 signaling and Akt activation and blocks colon tumor formation in high-fat diet-fed azoxymethane-treated mice. Int J Cancer 143:1797–1805

    Article  CAS  PubMed  Google Scholar 

  • Kolf CM, Cho E, Tuan RS (2007) Mesenchymal stromal cells. Biology of adult mesenchymal stem cells: regulation of niche, self-renewal and differentiation. Arthritis Res Ther 9:204

  • Lazarus HM, Haynesworth SE, Gerson SL, Rosenthal NS, Caplan AI (1995) Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells): implications for therapeutic use. Bone Marrow Transplant 16:557–564

    CAS  PubMed  Google Scholar 

  • Lee HS, Huang GT, Chiang H, Chiou LL, Chen MH, Hsieh CH, Jiang CC (2003) Multipotential mesenchymal stem cells from femoral bone marrow near the site of osteonecrosis. Stem Cells 21:190–199

    Article  CAS  PubMed  Google Scholar 

  • Lee BC, Shin N, Lee JY, Kang I, Kim JJ, Lee SE, Choi SW, Webster GA, Kang KS (2018) MIS416 enhances therapeutic functions of human umbilical cord blood-derived mesenchymal stem cells against experimental colitis by modulating systemic immune milieu. Front Immunol 9:1078

    Article  PubMed  PubMed Central  Google Scholar 

  • Lee JH, Yoon YM, Lee SH (2017) Hypoxic preconditioning promotes the bioactivities of mesenchymal stem cells via the HIF-1α-GRP78-Akt axis. Int J Mol Sci 18

  • Li Z (2013) CD133: a stem cell biomarker and beyond. Exp Hematol Oncol 2:17

    Article  PubMed  PubMed Central  Google Scholar 

  • Li X, Bai J, Ji X, Li R, Xuan Y, Wang Y (2014) Comprehensive characterization of four different populations of human mesenchymal stem cells as regards their immune properties, proliferation and differentiation. Int J Mol Med 34:695–704

    Article  PubMed  PubMed Central  Google Scholar 

  • Li CY, Wu XY, Tong JB, Yang XX, Zhao JL, Zheng QF, Zhao GB, Ma ZJ (2015) Comparative analysis of human mesenchymal stem cells from bone marrow and adipose tissue under xeno-free conditions for cell therapy. Stem Cell Res Ther 6:55

    Article  PubMed  PubMed Central  Google Scholar 

  • Liang X, Li C, Song J, Liu A, Wang C, Wang W, Kang Y, Sun D, Qian J, Zhang X (2023) HucMSC-exo promote mucosal healing in experimental colitis by accelerating intestinal stem cells and epithelium regeneration via Wnt signaling pathway. Int J Nanomedicine 18:2799–2818

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lim WC, Wang Y, Macdonald JK, Hanauer S (2016) Aminosalicylates for induction of remission or response in Crohn’s disease. Cochrane Database Syst Rev 7:Cd008870

  • Lin HD, Fong CY, Biswas A, Choolani M, Bongso A (2014) Human Wharton’s jelly stem cells, its conditioned medium and cell-free lysate inhibit the growth of human lymphoma cells. Stem Cell Rev Rep 10:573–586

    Article  PubMed  Google Scholar 

  • Liu A, Wang X, Liang X, Wang W, Li C, Qian J, Zhang X (2022) Human umbilical cord mesenchymal stem cells regulate immunoglobulin a secretion and remodel the diversification of intestinal microbiota to improve colitis. Front Cell Infect Microbiol 12:960208

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Liu A, Liang X, Wang W, Wang C, Song J, Guo J, Sun D, Wang D, Song M, Qian J, Zhang X (2023) Human umbilical cord mesenchymal stem cells ameliorate colon inflammation via modulation of gut microbiota-SCFAs-immune axis. Stem Cell Res Ther 14:271

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lozito TP, Tuan RS (2011) Mesenchymal stem cells inhibit both endogenous and exogenous MMPs via secreted TIMPs. J Cell Physiol 226:385–396

    Article  CAS  PubMed  Google Scholar 

  • Lu LL, Liu YJ, Yang SG, Zhao QJ, Wang X, Gong W, Han ZB, Xu ZS, Lu YX, Liu D, Chen ZZ, Han ZC (2006) Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials. Haematologica 91:1017–1026

    CAS  PubMed  Google Scholar 

  • Macrin D, Joseph JP, Pillai AA, Devi A (2017) Eminent sources of adult mesenchymal stem cells and their therapeutic imminence. Stem Cell Rev Rep 13:741–756

    Article  CAS  PubMed  Google Scholar 

  • Mahadev S, Young JM, Selby W, Solomon MJ (2011) Quality of life in perianal Crohn’s disease: what do patients consider important? Dis Colon Rectum 54:579–585

    Article  PubMed  Google Scholar 

  • Mannino G, Russo C, Maugeri G, Musumeci G, Vicario N, Tibullo D, Giuffrida R, Parenti R, Lo Furno D (2022) Adult stem cell niches for tissue homeostasis. J Cell Physiol 237:239–257

    Article  CAS  PubMed  Google Scholar 

  • Maria AT, Maumus M, Le Quellec A, Jorgensen C, Noël D, Guilpain P (2017) Adipose-derived mesenchymal stem cells in autoimmune disorders: state of the art and perspectives for systemic sclerosis. Clin Rev Allergy Immunol 52:234–259

    Article  CAS  PubMed  Google Scholar 

  • Marrazzo P, Crupi AN, Alviano F, Teodori L, Bonsi L (2019) Exploring the roles of MSC in infections: focus on bacterial diseases. J Mol Med (berl) 97:437–450

    Article  CAS  PubMed  Google Scholar 

  • Melief SM, Zwaginga JJ, Fibbe WE, Roelofs H (2013) Adipose tissue-derived multipotent stromal cells have a higher immunomodulatory capacity than their bone marrow-derived counterparts. Stem Cells Transl Med 2:455–463

    Article  PubMed  PubMed Central  Google Scholar 

  • Mendicino M, Bailey AM, Wonnacott K, Puri RK, Bauer SR (2014) MSC-based product characterization for clinical trials: an FDA perspective. Cell Stem Cell 14:141–145

    Article  CAS  PubMed  Google Scholar 

  • Mitchell KE, Weiss ML, Mitchell BM, Martin P, Davis D, Morales L, Helwig B, Beerenstrauch M, Abou-Easa K, Hildreth T, Troyer D, Medicetty S (2003) Matrix cells from Wharton’s jelly form neurons and glia. Stem Cells 21:50–60

    Article  CAS  PubMed  Google Scholar 

  • Mohamed-Ahmed S, Fristad I, Lie SA, Suliman S, Mustafa K, Vindenes H, Idris SB (2018) Adipose-derived and bone marrow mesenchymal stem cells: a donor-matched comparison. Stem Cell Res Ther 9:168

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Mohanty A, Polisetti N, Vemuganti GK (2020) Immunomodulatory properties of bone marrow mesenchymal stem cells. J Biosci 45

  • Moseley TA, Zhu M, Hedrick MH (2006) Adipose-derived stem and progenitor cells as fillers in plastic and reconstructive surgery. Plast Reconstr Surg 118:121s–128s

    Article  CAS  PubMed  Google Scholar 

  • Nagamura-Inoue T, He H (2014) Umbilical cord-derived mesenchymal stem cells: their advantages and potential clinical utility. World J Stem Cells 6:195–202

    Article  PubMed  PubMed Central  Google Scholar 

  • Najar M, Raicevic G, Boufker HI, Fayyad Kazan H, De Bruyn C, Meuleman N, Bron D, Toungouz M, Lagneaux L (2010) Mesenchymal stromal cells use PGE2 to modulate activation and proliferation of lymphocyte subsets: combined comparison of adipose tissue, Wharton’s Jelly and bone marrow sources. Cell Immunol 264:171–179

    Article  CAS  PubMed  Google Scholar 

  • Nakano M, Nagaishi K, Konari N, Saito Y, Chikenji T, Mizue Y, Fujimiya M (2016) Bone marrow-derived mesenchymal stem cells improve diabetes-induced cognitive impairment by exosome transfer into damaged neurons and astrocytes. Sci Rep 6:24805

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Nakatsuji T, Chen TH, Butcher AM, Trzoss LL, Nam SJ, Shirakawa KT, Zhou W, Oh J, Otto M, Fenical W, Gallo RL (2018) A commensal strain of Staphylococcus epidermidis protects against skin neoplasia. Sci Adv 4:eaao4502

  • Nasuno M, Arimura Y, Nagaishi K, Isshiki H, Onodera K, Nakagaki S, Watanabe S, Idogawa M, Yamashita K, Naishiro Y, Adachi Y, Suzuki H, Fujimiya M, Imai K, Shinomura Y (2014) Mesenchymal stem cells cancel azoxymethane-induced tumor initiation. Stem Cells 32:913–925

    Article  CAS  PubMed  Google Scholar 

  • Ng SC, Tang W, Ching JY, Wong M, Chow CM, Hui AJ, Wong TC, Leung VK, Tsang SW, Yu HH, Li MF, Ng KK, Kamm MA, Studd C, Bell S, Leong R, De Silva HJ, Kasturiratne A, Mufeena MNF, Ling KL, Ooi CJ, Tan PS, Ong D, Goh KL, Hilmi I, Pisespongsa P, Manatsathit S, Rerknimitr R, Aniwan S, Wang YF, Ouyang Q, Zeng Z, Zhu Z, Chen MH, Hu PJ, Wu K, Wang X, Simadibrata M, Abdullah M, Wu JC, Sung JJY, Chan FKL (2013) Incidence and phenotype of inflammatory bowel disease based on results from the Asia-pacific Crohn’s and colitis epidemiology study. Gastroenterology 145:158-165.e2

    Article  PubMed  Google Scholar 

  • Ng SC, Shi HY, Hamidi N, Underwood FE, Tang W, Benchimol EI, Panaccione R, Ghosh S, Wu JCY, Chan FKL, Sung JJY, Kaplan GG (2017) Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet 390:2769–2778

    Article  PubMed  Google Scholar 

  • Ocansey DKW, Pei B, Xu X, Zhang L, Olovo CV, Mao F (2021) Cellular and molecular mediators of lymphangiogenesis in inflammatory bowel disease. J Transl Med 19:254

    Article  PubMed  PubMed Central  Google Scholar 

  • Oh JY, Ko JH, Lee HJ, Yu JM, Choi H, Kim MK, Wee WR, Prockop DJ (2014) Mesenchymal stem/stromal cells inhibit the NLRP3 inflammasome by decreasing mitochondrial reactive oxygen species. Stem Cells 32:1553–1563

    Article  CAS  PubMed  Google Scholar 

  • Panés J, Rimola J (2017) Perianal fistulizing Crohn’s disease: pathogenesis, diagnosis and therapy. Nat Rev Gastroenterol Hepatol 14:652–664

    Article  PubMed  Google Scholar 

  • Panés J, García-Olmo D, Van Assche G, Colombel JF, Reinisch W, Baumgart DC, Dignass A, Nachury M, Ferrante M, Kazemi-Shirazi L, Grimaud JC, De la Portilla F, Goldin E, Richard MP, Leselbaum A, Danese S (2016) Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn’s disease: a phase 3 randomised, double-blind controlled trial. Lancet 388:1281–1290

    Article  PubMed  Google Scholar 

  • Pardali E, Sanchez-Duffhues G, Gomez-Puerto MC, Ten Dijke P (2017) TGF-β-induced endothelial-mesenchymal transition in fibrotic diseases. Int J Mol Sci 18

  • Park SR, Kim JW, Jun HS, Roh JY, Lee HY, Hong IS (2018) Stem cell secretome and its effect on cellular mechanisms relevant to wound healing. Mol Ther 26:606–617

    Article  CAS  PubMed  Google Scholar 

  • Pavlushina SV, Orlova TG, Tabagari DZ (1984) Isolation of mononuclear cells from the bone marrow of patients with hemoblastoses using one-step ficoll-verographin density gradient separation. Eksp Onkol 6:68–70

    CAS  PubMed  Google Scholar 

  • Petrenko Y, Vackova I, Kekulova K, Chudickova M, Koci Z, Turnovcova K, Kupcova Skalnikova H, Vodicka P, Kubinova S (2020) A comparative analysis of multipotent mesenchymal stromal cells derived from different sources, with a focus on neuroregenerative potential. Sci Rep 10:4290

    Article  PubMed  PubMed Central  Google Scholar 

  • Pikuła M, Marek-Trzonkowska N, Wardowska A, Renkielska A, Trzonkowski P (2013) Adipose tissue-derived stem cells in clinical applications. Expert Opin Biol Ther 13:1357–1370

    Article  PubMed  Google Scholar 

  • Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284:143–147

    Article  CAS  PubMed  Google Scholar 

  • Qi L, Wu J, Zhu S, Wang X, Lv X, Liu C, Liu YJ, Chen J (2022) Mesenchymal stem cells alleviate inflammatory bowel disease via Tr1 cells. Stem Cell Rev Rep 18:2444–2457

    Article  CAS  PubMed  Google Scholar 

  • Qian C, Meng Q, Lu J, Zhang L, Li H, Huang B (2020) Human amnion mesenchymal stem cells restore spermatogenesis in mice with Busulfan-induced testis toxicity by inhibiting apoptosis and oxidative stress. Stem Cell Res Ther 11:290

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Reinisch A, Etchart N, Thomas D, Hofmann NA, Fruehwirth M, Sinha S, Chan CK, Senarath-Yapa K, Seo EY, Wearda T, Hartwig UF, Beham-Schmid C, Trajanoski S, Lin Q, Wagner W, Dullin C, Alves F, Andreeff M, Weissman IL, Longaker MT, Schallmoser K, Majeti R, Strunk D (2015) Epigenetic and in vivo comparison of diverse MSC sources reveals an endochondral signature for human hematopoietic niche formation. Blood 125:249–260

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ren C, Kumar S, Chanda D, Chen J, Mountz JD, Ponnazhagan S (2008) Therapeutic potential of mesenchymal stem cells producing interferon-alpha in a mouse melanoma lung metastasis model. Stem Cells 26:2332–2338

    Article  CAS  PubMed  Google Scholar 

  • Reza A, Choi YJ, Yasuda H, Kim JH (2016) Human adipose mesenchymal stem cell-derived exosomal-miRNAs are critical factors for inducing anti-proliferation signalling to A2780 and SKOV-3 ovarian cancer cells. Sci Rep 6:38498

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Rhee KJ, Lee JI, Eom YW (2015) Mesenchymal stem cell-mediated effects of tumor support or suppression. Int J Mol Sci 16:30015–30033

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Rioux JD, Xavier RJ, Taylor KD, Silverberg MS, Goyette P, Huett A, Green T, Kuballa P, Barmada MM, Datta LW, Shugart YY, Griffiths AM, Targan SR, Ippoliti AF, Bernard EJ, Mei L, Nicolae DL, Regueiro M, Schumm LP, Steinhart AH, Rotter JI, Duerr RH, Cho JH, Daly MJ, Brant SR (2007) Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat Genet 39:596–604

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Romanov YA, Svintsitskaya VA, Smirnov VN (2003) Searching for alternative sources of postnatal human mesenchymal stem cells: candidate MSC-like cells from umbilical cord. Stem Cells 21:105–110

    Article  PubMed  Google Scholar 

  • Ryu H, Oh JE, Rhee KJ, Baik SK, Kim J, Kang SJ, Sohn JH, Choi E, Shin HC, Kim YM, Kim HS, Bae KS, Eom YW (2014) Adipose tissue-derived mesenchymal stem cells cultured at high density express IFN-β and suppress the growth of MCF-7 human breast cancer cells. Cancer Lett 352:220–227

    Article  CAS  PubMed  Google Scholar 

  • Saito K, Sakaguchi M, Maruyama S, Iioka H, Putranto EW, Sumardika IW, Tomonobu N, Kawasaki T, Homma K, Kondo E (2018) Stromal mesenchymal stem cells facilitate pancreatic cancer progression by regulating specific secretory molecules through mutual cellular interaction. J Cancer 9:2916–2929

    Article  PubMed  PubMed Central  Google Scholar 

  • Schneider S, Unger M, Van Griensven M, Balmayor ER (2017) Adipose-derived mesenchymal stem cells from liposuction and resected fat are feasible sources for regenerative medicine. Eur J Med Res 22:17

    Article  PubMed  PubMed Central  Google Scholar 

  • Secunda R, Vennila R, Mohanashankar AM, Rajasundari M, Jeswanth S, Surendran R (2015) Isolation, expansion and characterisation of mesenchymal stem cells from human bone marrow, adipose tissue, umbilical cord blood and matrix: a comparative study. Cytotechnology 67:793–807

    Article  CAS  PubMed  Google Scholar 

  • Shanahan F (2002) Crohn’s disease. Lancet 359:62–69

    Article  CAS  PubMed  Google Scholar 

  • Shi S, Gronthos S (2003) Perivascular niche of postnatal mesenchymal stem cells in human bone marrow and dental pulp. J Bone Miner Res 18:696–704

    Article  PubMed  Google Scholar 

  • Silva-Carvalho A, Cardoso MH, Alencar-Silva T, Bogéa GMR, Carvalho JL, Franco OL, Saldanha-Araujo F (2022) Dissecting the relationship between antimicrobial peptides and mesenchymal stem cells. Pharmacol Ther 233:108021

    Article  CAS  PubMed  Google Scholar 

  • Smyth TJ, Redzic JS, Graner MW, Anchordoquy TJ (2014) Examination of the specificity of tumor cell derived exosomes with tumor cells in vitro. Biochim Biophys Acta 1838:2954–2965

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Song N, Armstrong AD, Li F, Ouyang H, Niyibizi C (2014) Multipotent mesenchymal stem cells from human subacromial bursa: potential for cell based tendon tissue engineering. Tissue Eng Part A 20:239–249

    Article  CAS  PubMed  Google Scholar 

  • Springer TA (1994) Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76:301–314

    Article  CAS  PubMed  Google Scholar 

  • Stavely R, Nurgali K (2020) The emerging antioxidant paradigm of mesenchymal stem cell therapy. Stem Cells Transl Med 9:985–1006

    Article  PubMed  PubMed Central  Google Scholar 

  • Strioga M, Viswanathan S, Darinskas A, Slaby O, Michalek J (2012) Same or not the same? Comparison of adipose tissue-derived versus bone marrow-derived mesenchymal stem and stromal cells. Stem Cells Dev 21:2724–2752

    Article  CAS  PubMed  Google Scholar 

  • Strober W, Fuss I, Mannon P (2007) The fundamental basis of inflammatory bowel disease. J Clin Invest 117:514–521

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Takahara K, Ii M, Inamoto T, Nakagawa T, Ibuki N, Yoshikawa Y, Tsujino T, Uchimoto T, Saito K, Takai T, Tanda N, Minami K, Uehara H, Komura K, Hirano H, Nomi H, Kiyama S, Asahi M, Azuma H (2016) microRNA-145 mediates the inhibitory effect of adipose tissue-derived stromal cells on prostate cancer. Stem Cells Dev 25:1290–1298

    Article  CAS  PubMed  Google Scholar 

  • Tang RJ, Shen SN, Zhao XY, Nie YZ, Xu YJ, Ren J, Lv MM, Hou YY, Wang TT (2015) Mesenchymal stem cells-regulated Treg cells suppress colitis-associated colorectal cancer. Stem Cell Res Ther 6:71

    Article  PubMed  PubMed Central  Google Scholar 

  • Torre P, Flores AI (2020) Current status and future prospects of perinatal stem cells. Genes (Basel) 12

  • Ullah I, Subbarao RB, Rho GJ (2015) Human mesenchymal stem cells – current trends and future prospective. Biosci Rep 35

  • Vaculik C, Schuster C, Bauer W, Iram N, Pfisterer K, Kramer G, Reinisch A, Strunk D, Elbe-Bürger A (2012) Human dermis harbors distinct mesenchymal stromal cell subsets. J Invest Dermatol 132:563–574

    Article  CAS  PubMed  Google Scholar 

  • Valle-Prieto A, Conget PA (2010) Human mesenchymal stem cells efficiently manage oxidative stress. Stem Cells Dev 19:1885–1893

    Article  CAS  PubMed  Google Scholar 

  • Van Harmelen V, Röhrig K, Hauner H (2004) Comparison of proliferation and differentiation capacity of human adipocyte precursor cells from the omental and subcutaneous adipose tissue depot of obese subjects. Metabolism 53:632–637

    Article  PubMed  Google Scholar 

  • Varghese J, Griffin M, Mosahebi A, Butler P (2017) Systematic review of patient factors affecting adipose stem cell viability and function: implications for regenerative therapy. Stem Cell Res Ther 8:45

    Article  PubMed  PubMed Central  Google Scholar 

  • Vendramini-Costa DB, Carvalho JE (2012) Molecular link mechanisms between inflammation and cancer. Curr Pharm Des 18:3831–3852

    Article  CAS  PubMed  Google Scholar 

  • Vizoso FJ, Eiro N, Cid S, Schneider J, Perez-Fernandez R (2017) Mesenchymal stem cell secretome: toward cell-free therapeutic strategies in regenerative medicine. Int J Mol Sci 18

  • Walton KL, Johnson KE, Harrison CA (2017) Targeting TGF-β mediated SMAD signaling for the prevention of fibrosis. Front Pharmacol 8:461

    Article  PubMed  PubMed Central  Google Scholar 

  • Wang D, Dubois RN (2013) The role of anti-inflammatory drugs in colorectal cancer. Annu Rev Med 64:131–144

    Article  CAS  PubMed  Google Scholar 

  • Wang Z, Yan X (2013) CD146, a multi-functional molecule beyond adhesion. Cancer Lett 330:150–162

    Article  CAS  PubMed  Google Scholar 

  • Wang WQ, Dong K, Zhou L, Jiao GH, Zhu CZ, Li WW, Yu G, Wu WT, Chen S, Sun ZN, Wang YM, Liu WT, Zhang J, Wang BM, Feng XM (2015) IL-37b gene transfer enhances the therapeutic efficacy of mesenchumal stromal cells in DSS-induced colitis mice. Acta Pharmacol Sin 36:1377–1387

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wang G, Joel MDM, Yuan J, Wang J, Cai X, Ocansey DKW, Yan Y, Qian H, Zhang X, Xu W, Mao F (2020) Human umbilical cord mesenchymal stem cells alleviate inflammatory bowel disease by inhibiting ERK phosphorylation in neutrophils. Inflammopharmacology 28:603–616

    Article  CAS  PubMed  Google Scholar 

  • Wang D, Xue H, Tan J, Liu P, Qiao C, Pang C, Zhang L (2022) Bone marrow mesenchymal stem cells-derived exosomes containing miR-539-5p inhibit pyroptosis through NLRP3/caspase-1 signalling to alleviate inflammatory bowel disease. Inflamm Res 71:833–846

    Article  CAS  PubMed  Google Scholar 

  • Wei J, Zhang Y, Chen C, Feng X, Yang Z, Feng J, Jiang Q, Fu J, Xuan J, Gao H, Liao L, Wang F (2023a) Efficacy and safety of allogeneic umbilical cord-derived mesenchymal stem cells for the treatment of complex perianal fistula in Crohn’s disease: a pilot study. Stem Cell Res Ther 14:311

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wei Z, Hang S, Wiredu Ocansey DK, Zhang Z, Wang B, Zhang X, Mao F (2023b) Human umbilical cord mesenchymal stem cells derived exosome shuttling mir-129-5p attenuates inflammatory bowel disease by inhibiting ferroptosis. J Nanobiotechnology 21:188

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Witkowska-Zimny M, Wrobel E (2011) Perinatal sources of mesenchymal stem cells: Wharton’s jelly, amnion and chorion. Cell Mol Biol Lett 16:493–514

    Article  PubMed  PubMed Central  Google Scholar 

  • Wu S, Ju GQ, Du T, Zhu YJ, Liu GH (2013) Microvesicles derived from human umbilical cord Wharton’s jelly mesenchymal stem cells attenuate bladder tumor cell growth in vitro and in vivo. PLoS ONE 8:e61366

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wu X, Dao Thi VL, Huang Y, Billerbeck E, Saha D, Hoffmann HH, Wang Y, Silva LAV, Sarbanes S, Sun T, Andrus L, Yu Y, Quirk C, Li M, Macdonald MR, Schneider WM, An X, Rosenberg BR, Rice CM (2018) Intrinsic immunity shapes viral resistance of stem cells. Cell 172:423-438.e25

    Article  CAS  PubMed  Google Scholar 

  • Xu L, Liu Y, Sun Y, Wang B, Xiong Y, Lin W, Wei Q, Wang H, He W, Wang B, Li G (2017) Tissue source determines the differentiation potentials of mesenchymal stem cells: a comparative study of human mesenchymal stem cells from bone marrow and adipose tissue. Stem Cell Res Ther 8:275

    Article  PubMed  PubMed Central  Google Scholar 

  • Xu Y, Tang X, Fang A, Yan J, Kofi Wiredu Ocansey D, Zhang X, Mao F (2022) HucMSC-Ex carrying miR-203a-3p.2 ameliorates colitis through the suppression of caspase11/4-induced macrophage pyroptosis. Int Immunopharmacol 110:108925

  • Yan JB, Luo MM, Chen ZY, He BH (2020) The function and role of the Th17/Treg cell balance in inflammatory bowel disease. J Immunol Res 2020:8813558

    Article  PubMed  PubMed Central  Google Scholar 

  • Yang J, Liu XX, Fan H, Tang Q, Shou ZX, Zuo DM, Zou Z, Xu M, Chen QY, Peng Y, Deng SJ, Liu YJ (2015) Extracellular vesicles derived from bone marrow mesenchymal stem cells protect against experimental colitis via attenuating colon inflammation, oxidative stress and apoptosis. PLoS ONE 10:e0140551

    Article  PubMed  PubMed Central  Google Scholar 

  • Yang S, Liang X, Song J, Li C, Liu A, Luo Y, Ma H, Tan Y, Zhang X (2021) A novel therapeutic approach for inflammatory bowel disease by exosomes derived from human umbilical cord mesenchymal stem cells to repair intestinal barrier via TSG-6. Stem Cell Res Ther 12:315

    Article  PubMed  PubMed Central  Google Scholar 

  • Yang F, Ni B, Liu Q, He F, Li L, Zhong X, Zheng X, Lu J, Chen X, Lin H, Xu R, He Y, Zhang Q, Zou X, Chen W (2022) Human umbilical cord-derived mesenchymal stem cells ameliorate experimental colitis by normalizing the gut microbiota. Stem Cell Res Ther 13:475

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ye Y, Zhang X, Su D, Ren Y, Cheng F, Yao Y, Shi G, Ji Y, Chen S, Shi P, Dai L, Su X, Deng H (2022) Therapeutic efficacy of human adipose mesenchymal stem cells in Crohn’s colon fibrosis is improved by IFN-γ and kynurenic acid priming through indoleamine 2,3-dioxygenase-1 signaling. Stem Cell Res Ther 13:465

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Yu H, Yang X, Xiao X, Xu M, Yang Y, Xue C, Li X, Wang S, Zhao RC (2021) Human adipose mesenchymal stem cell-derived exosomes protect mice from DSS-induced inflammatory bowel disease by promoting intestinal-stem-cell and epithelial regeneration. Aging Dis 12:1423–1437

    Article  PubMed  PubMed Central  Google Scholar 

  • Zhang LJ, Gallo RL (2016) Antimicrobial peptides. Curr Biol 26:R14–R19

    Article  CAS  PubMed  Google Scholar 

  • Zhang X, Hu X, Rao X (2017) Apoptosis induced by Staphylococcus aureus toxins. Microbiol Res 205:19–24

    Article  CAS  PubMed  Google Scholar 

  • Zhang L, Yuan J, Kofi Wiredu Ocansey D, Lu B, Wan A, Chen X, Zhang X, Qiu W, Mao F (2022b) Exosomes derived from human umbilical cord mesenchymal stem cells regulate lymphangiogenesis via the miR-302d-3p/VEGFR3/AKT axis to ameliorate inflammatory bowel disease. Int Immunopharmacol 110:109066

    Article  CAS  PubMed  Google Scholar 

  • Zhang HM, Yuan S, Meng H, Hou XT, Li J, Xue JC, Li Y, Wang Q, Nan JX, Jin XJ, Zhang QG (2022a) Stem cell-based therapies for inflammatory bowel disease. Int J Mol Sci 23

  • Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ, Benhaim P, Lorenz HP, Hedrick MH (2001) Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 7:211–228

    Article  CAS  PubMed  Google Scholar 

  • Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang JI, Mizuno H, Alfonso ZC, Fraser JK, Benhaim P, Hedrick MH (2002) Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 13:4279–4295

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

Not applicable.

Funding

This work was supported by grants from the Tai Shan Young Scholar Foundation of Shandong Province [tsqn202103190]; the National Natural Science Foundation of China [82270562, 82200591]; Shandong Provincial Traditional Chinese Medicine Science and Technology Program [M-2023173, Q-2022134].

Author information

Authors and Affiliations

Authors

Contributions

Lihao Shi wrote the manuscript and designed the figures. Leilei Chen, Xizhuang Gao, Xufan Sun, Guiyuan Jin, Yonghong Yang, Yiming Shao, and Fengqin Zhu revised the manuscript. Guangxi Zhou conceived the idea and designed the manuscript. All authors gave final approval for the submission. All authors agree to be accountable for all aspects of the work and all authors read and approved the final manuscript.

Corresponding author

Correspondence to Guangxi Zhou.

Ethics declarations

Conflict of interest

All authors declare no competing interests.

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Data availability

Not applicable.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shi, L., Chen, L., Gao, X. et al. Comparison of different sources of mesenchymal stem cells: focus on inflammatory bowel disease. Inflammopharmacol (2024). https://doi.org/10.1007/s10787-024-01468-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s10787-024-01468-1

Keywords

Navigation